NZYM B Novozymes A/S Class B

Novonesis named a Great Employer to Work For in North Carolina

Novonesis named a Great Employer to Work For in North Carolina

Franklinton, North Carolina, March 09, 2026 (GLOBE NEWSWIRE) -- , a global leader in biosolutions, has been named a 2026 Great Employer to Work for in North Carolina by Best Companies Group (BCG), marking the company’s first time earning this prestigious recognition. BCG is a trusted leader in workplace culture research and recognition, distinguishing top companies around the United States for more than 20 years. The honor is based entirely on confidential employee feedback and a comprehensive evaluation of workplace practices, culture, and leadership. 

Novonesis ranked 6th on the list of Great Employers to Work for in North Carolina. With more than 700 employees across North Carolina, Novonesis’ recognition reflects its commitment to building a workplace where people can be themselves, grow their careers, and contribute to meaningful work that improves lives and the planet. 

“At Novonesis, we believe people are at the heart of everything we do,” said Tue Micheelsen, President of Novonesis North America. “Being named a Great Employer is especially meaningful because it is rooted in direct employee feedback. Our teams in North Carolina are passionate about our purpose — to better our world with biology — and this recognition affirms our commitment to creating a culture where people feel respected, supported, and inspired to make a difference.” 

Novonesis’ workplace culture is built around the idea of ‘The biological choice’ — offering employees a career that matters. Across its North Carolina operations, employees are empowered to bring their authentic selves to work, collaborate across disciplines, and develop professionally while advancing biosolutions that transform industries ranging from food and agriculture to health, energy, and manufacturing. 

With major operations in Franklinton, Morrisville, and Durham, Novonesis employs scientists, engineers, manufacturing specialists, and corporate professionals, including teams at North America’s largest multipurpose enzyme manufacturing facility in Franklinton. Together, these teams drive innovation across more than 30 industries, helping customers produce more sustainably, reduce environmental impact, and improve everyday life. 

“Our culture is rooted in respect, inclusion, and continuous learning,” said Darren Alfano, Head of People & Organization at Novonesis. “We want every colleague to feel they belong, are challenged to grow, and can see the real-world impact of their work. This recognition reinforces that Novonesis is not just a great place to work, it’s a place to build a purpose-driven career.” 

Novonesis has proudly called North Carolina home for more than four decades and continues to invest in the region through workforce development, advanced manufacturing, STEM education partnerships, and community engagement. The company collaborates closely with state agencies, academic institutions, and industry organizations to strengthen the state’s leadership in biotechnology and biomanufacturing while creating high-quality jobs and expanding career pathways. 

“We are proud to honor Novonesis with this certification,” said Jaime Raul Zepeda, Executive Vice President of Best Companies Group. “Their commitment to employee well-being, innovation, and excellence truly embodies what it means to be a Great Employer in North Carolina.” 

 See all the 2026 Great Employers to Work for in North Carolina winners . 

### 

About Novonesis  

Novonesis is a global company leading the era of biosolutions. By leveraging the power of microbiology with science, we transform the way the world produces, consumes, and lives. In more than 30 industries, our biosolutions are already creating value for millions of consumers and benefitting the planet. Our 10,000 people worldwide work closely with our partners and customers to transform business with biology.   

Learn more on    

MEDIA RELATIONS – NORTH AMERICA  
Kathy Humphrey   



Head of Communications, North America  



Phone: 1 919-494-8764  



  

Attachment



EN
09/03/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE

Novonesis named a Great Employer to Work For in North Carolina

Novonesis named a Great Employer to Work For in North Carolina Franklinton, North Carolina, March 09, 2026 (GLOBE NEWSWIRE) -- , a global leader in biosolutions, has been named a 2026 Great Employer to Work for in North Carolina by Best Companies Group (BCG), marking the company’s first time earning this prestigious recognition. BCG is a trusted leader in workplace culture research and recognition, distinguishing top companies around the United States for more than 20 years. The honor is based entirely on confidential employee feedback and a comprehensive evaluation of workplace practices...

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. Please read the full announcement in PDF. Attachment

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. Please read the full annuncement in PDF. Attachment

 PRESS RELEASE

Invitation to the 2026 Annual General Meeting

Invitation to the 2026 Annual General Meeting The Annual General Meeting of Novonesis (Novozymes A/S) will be held on Monday March 23, 2026 at 4:00 pm CET at Gammel Venlighedsvej 14, DK-2970 Hoersholm, Denmark. There will also be access to the meeting from the entrance at Boege Alle 10-12, DK-2970 Hoersholm, Denmark. For further information, please refer to the enclosed invitation to convene the Annual General Meeting, including the agenda and complete proposals. BOARD OF DIRECTORSThe Board of Directors proposes the re-election of Cornelis (Cees) de Jong as Chair of the Board and Heine Da...

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The Executive Leadership Team members eligible for the Novozymes A/S 2023-2025 incentive program has on February 25, 2026, received the allocated shares. An overview of the number and value of shares allotted is provided...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch